论文部分内容阅读
目的:了解鲍曼不动杆菌的科室分布及耐药性,给临床合理用药提供参考。方法:收集我院2008-01/2008-12住院各临床科室送检的痰、引流液、伤口分泌物、脑脊液等标本分离出的鲍曼不动杆菌301株,了解其临床感染的特点及其耐药率的变化。结果:鲍曼不动杆菌临床分布以ICU最多,分离标本痰液最高,12种抗菌药物对鲍曼不动杆菌的耐药率呈上升趋势;ICU耐药率明显高于其他科室,头孢哌酮舒巴坦对其较敏感。结论:鲍曼不动杆菌临床上应严格执行无菌操作技术及诊疗规范,以避免其感染,严格掌握抗生素使用指征,选择应用对细菌敏感的药物。
Objective: To understand the department of Acinetobacter baumannii distribution and drug resistance, to provide a reference for clinical rational use of drugs. Methods: To collect 301 strains of Acinetobacter baumannii isolated from sputum, drainage fluid, wound secretion and cerebrospinal fluid in various clinical departments of our hospital from January 2008 to December 2008 to understand the characteristics of their clinical infection and their clinical significance Resistance rate changes. Results: The clinical distribution of Acinetobacter baumannii was the highest with the highest ICU and the highest sputum from the isolated samples. The resistance rates of 12 kinds of antibacterials to Acinetobacter baumannii were on the rise. The drug resistance rate of ICU was obviously higher than that of other departments, cefoperazone Sulbactam is more sensitive to it. Conclusion: Acinetobacter baumannii clinical practice should be strictly enforced aseptic technique and treatment practices to avoid infection, strict control of indications for antibiotics, the choice of the application of bacteria-sensitive drugs.